Similarly, mRNA levels of Pgc1α were lowered in our cellular models of MASLD, while silencing MCU restored the reduced Pgc1α mRNA in hepatocytes exposed to OPA toxicity (Fig. S7C). Here, MCU is linked to metabolic dysfunction-associated steatotic liver disease.